eGFR > 60 mL/min/1.73m2 a | PRD b | ESRD c | P values | |
---|---|---|---|---|
No. of patients | 7 | 14 | 4 | |
% of patients | 28 | 56 | 16 | |
Age, year | 61 | 64 | 68 | 0.8 |
Median follow-up, months | 8.3 | 16.5 | 21.6 | 0.3 |
Mean eGFR, ml/min/1.73m2 | ||||
At biopsy | 28.9 | 20.9 | 17.5 | 0.6 |
Follow-up | 84.6 | 37.5 | – | < 0.001 |
Mean proteinuria at biopsy, g/day | 3.5 | 5.5 | 6.5 | 0.2 |
Corticosteroids, % of patients | 0 | 64 | 25 | 0.01 |
Median infection-renal injury delay, days (IQR) | 13 (8.5–36) | 23 (17.8–69) | 13 (10–47.3) | 0.3 |
Histologic pattern (acute/subacute/resolving, %) | 29/57/14 | 29/64/7 | 50/25/25 | 0.1 |
Global glomerulosclerosis, % of glomeruli | 13 | 18 | 44 | 0.2 |
Crescentic proliferation, % of glomeruli | 4 | 6 | 5 | 0.9 |
Interstitial inflammation score, mean | 0.9 | 0.9 | 1.5 | 0.2 |
Acute tubular injury score, mean | 1.6 | 1.8 | 1.75 | 0.8 |
IF/TA score, mean | 0.9 | 1.6 | 2.5 | 0.02 |
Arteriosclerosis, mean | 2 | 1.8 | 2 | 0.6 |